Feebris’ team combines expertise in biomedical engineering, machine learning, global health, and business. More importantly, they are unreasonably passionate about our vision to transform healthcare globally and make it equitable, personalized, and patient-driven.
Feebris is an AI company developing world-class machine learning algorithms for precision detection of complex respiratory conditions in the field. Diagnosing these conditions typically requires an experienced pulmonologist, blood tests, and imaging, but Feebris’ software platform connects to existing medical sensors and can be used intuitively by non-doctor users, outside the clinic, to detect respiratory issues early and avoid complications and hospitalizations.
Total Funding: $1,389,211
Funding Stage: Funded
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2017
